Research & Innovation
Science
Pipeline
About us
CEO Message
Company Profile
Team
News
Contact
JA
Home
News
News
All post
News
News
Dr. Yoshikatsu Kanai’s BNCT Project with APL1202 Selected for AMED’s FY2025 P‑PROMOTE Program
2025.06.04
News
Atransen Pharma Raises JPY 1.13 Billion in Series A Funding
2025.05.30
News
APL1101 Selected for AMED’s Strengthening Program for Pharmaceutical Startup Ecosystem
2025.03.12
News
Atransen Pharma CSO and the collaboration team Unveil LAT1 Structural Insights in Nature Communications
2025.02.18
News
MOU Signed to Advance Research and Development Initiatives
2024.12.25
News
we have launched our official website.
2024.11.12
Load more
LOADING...
News
Dr. Yoshikatsu Kanai’s BNCT Project with APL1202 Selected for AMED’s FY2025 P‑PROMOTE Program
2025.06.04
News
Atransen Pharma Raises JPY 1.13 Billion in Series A Funding
2025.05.30
News
APL1101 Selected for AMED’s Strengthening Program for Pharmaceutical Startup Ecosystem
2025.03.12
News
Atransen Pharma CSO and the collaboration team Unveil LAT1 Structural Insights in Nature Communications
2025.02.18
News
MOU Signed to Advance Research and Development Initiatives
2024.12.25
News
we have launched our official website.
2024.11.12
Load more
LOADING...
Research & Innovation
Science
Pipeline
About us
CEO Message
Company Profile
Team
News
Contact
JA
